Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 8 min ago
Peer-reviewedCC BYJournal of cardiology cases

Managing a mavacamten non-responder in obstructive hypertrophic cardiomyopathy: A case report

  • Smita Scholtz1
  • Felix Langkamp1
  • Volker Rudolph1
  • Jan Michael Federspiel2
  • Vasco Sequeira3
  1. 1Ruhr-University Bochum, Heart- and Diabetescenter NRW, Department of General and Interventional Cardiology/Angiology, Bad Oeynhausen, Germany
  2. 2Saarland University, Faculty of Medicine, Institute of Legal Medicine, Homburg (Saar), Germany
  3. 3Comprehensive Heart Failure Center (CHFC), University Clinic Würzburg, Würzburg, Germany
Read full textPDFCite

Related

  1. Real-World Implementation and Clinical Outcomes of Mavacamten in an Underserved Urban Cohort With Obstructive Hypertrophic Cardiomyopathy
    J. Bock, S. Murthy, A. L. Schenone +1
    medRxivPreprintCC BY-NC-NDFull textCardiovascular medicinemedRxiv
  2. Clinical effectiveness of mavacamten on cardiac function and disease-related indicators in patients with obstructive hypertrophic cardiomyopathy
    Ya-Nan Shi, Jia-Jia Huang, Hong-Zhi Liu +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossref
  3. Long-term mavacamten exposure reduces force and sarcomere density in a human induced pluripotent stem cell–derived model of hypertrophic cardiomyopathy
    Marianna Langione, Lucrezia Giammarino, Roberto Semeraro +16
    Cardiovascular ResearchPeer-reviewedLicence not statedFull textCardiovascular medicineHAL
  4. Mavacamten shows broad benefit in human and mouse models of MYBPC3-related hypertrophic cardiomyopathy
    Laura Sen-Martín, Ángel Fernández-Trasancos, Miguel Á. López-Unzu +34
    Nature Cardiovascular ResearchPeer-reviewedPublisher termsFull textCardiovascular medicineHAL
  5. Mavacamten improves energy balance in a pre-clinical model of RASopathy-associated hypertrophic cardiomyopathy
    Andrea Ruiz-Velasco, Charlène Jouve, Lucille Deshayes +3
    Pediatric ResearchPeer-reviewedCC BY-NC-SA 4.0Full text1 citedGeneral biologyCardiovascular medicineHAL

Cite

BibTeXRIS
BibTeX
@article{scholtz2026managing,
  title = {{Managing a mavacamten non-responder in obstructive hypertrophic cardiomyopathy: A case report}},
  author = {Smita Scholtz and Felix Langkamp and Volker Rudolph and Jan Michael Federspiel and Vasco Sequeira},
  journal = {Journal of cardiology cases},
  year = {2026},
  month = jul,
  url = {https://europepmc.org/article/PMC/PMC13670375},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Managing a mavacamten non-responder in obstructive hypertrophic cardiomyopathy: A case report
AU  - Smita Scholtz
AU  - Felix Langkamp
AU  - Volker Rudolph
AU  - Jan Michael Federspiel
AU  - Vasco Sequeira
PY  - 2026
DA  - 2026/07/09
JO  - Journal of cardiology cases
UR  - https://europepmc.org/article/PMC/PMC13670375
SN  - 1878-5409
ER  -